Viseven Secures Another Round of Funding for Cutting-Edge Pharma Marketing Solutions

Viseven, a leading MarTech Service Provider dedicated to the Life Sciences sector, is excited to announce a significant funding round, raising an impressive $10 million to enhance its operations and expand its innovative digital solutions for the pharmaceutical industry.

With a talented global team of over 700 professionals, Viseven stands out for its commitment to delivering tailored marketing services that encompass omnichannel marketing, eDetailing, and digital transformation strategies exclusively for Pharma, Healthcare, and Life Sciences organizations.

The recently secured funds will be channeled into further developing the eWizard Content Experience Platform, which has already been proven to streamline content creation and distribution processes for clients, allowing them to engage their audiences with personalized, precision-driven materials.

This investment is crucial as Viseven aims to bolster its capabilities in modular content creation and localization technologies, thus maximizing global reach and effectiveness for its clientele.

Additionally, the funds will support the company’s ongoing mission to drive digital transformation in the life sciences by enhancing its innovative go-to marketing technology and expanding its services in customer journey management and interactive visual aids.

As Viseven continues to play a pivotal role in reshaping the pharma marketing landscape, the company remains ready and committed to helping organizations navigate the complexities of digital engagement, ensuring that every piece of content thrives in any environment or channel.

This funding underscores Viseven's dedication to empowering its clients with the tools necessary for success in an increasingly digital world.